SE0002354D0 - New formulation - Google Patents
New formulationInfo
- Publication number
- SE0002354D0 SE0002354D0 SE0002354A SE0002354A SE0002354D0 SE 0002354 D0 SE0002354 D0 SE 0002354D0 SE 0002354 A SE0002354 A SE 0002354A SE 0002354 A SE0002354 A SE 0002354A SE 0002354 D0 SE0002354 D0 SE 0002354D0
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- new formulation
- formulations
- betablocker
- atherosclerosis
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 1
- 229940127226 anticholesterol agent Drugs 0.000 abstract 1
- 239000002876 beta blocker Substances 0.000 abstract 1
- 229940097320 beta blocking agent Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
ARP010102759A AR028699A1 (es) | 2000-06-22 | 2001-06-11 | Nueva formulacion |
RU2002133205/15A RU2271802C2 (ru) | 2000-06-22 | 2001-06-15 | Применение фармацевтического препарата, содержащего бета-блокатор |
EP01941409A EP1296716B1 (en) | 2000-06-22 | 2001-06-15 | Use of a beta-blocker for the treatment of atherosclerosis |
ES01941409T ES2274892T3 (es) | 2000-06-22 | 2001-06-15 | Uso de un betabloqueante para el tratamiento de aterosclerosis. |
CZ20024181A CZ20024181A3 (cs) | 2000-06-22 | 2001-06-15 | Farmaceutické prostředky obsahující betablokátor |
EEP200200703A EE200200703A (et) | 2000-06-22 | 2001-06-15 | Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm |
AT01941409T ATE344675T1 (de) | 2000-06-22 | 2001-06-15 | Verwendung eines betablockers zur behandlung von atherosklerose |
MXPA02012957A MXPA02012957A (es) | 2000-06-22 | 2001-06-15 | Formulacion nueva. |
IL15324501A IL153245A0 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
AU2001274766A AU2001274766A1 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
NZ523188A NZ523188A (en) | 2000-06-22 | 2001-06-15 | Use of a betablocker in the manufacture of a medicament to treat artherosclerosis |
US10/311,201 US20030191177A1 (en) | 2000-06-22 | 2001-06-15 | Fomulation |
KR1020027017474A KR20030010750A (ko) | 2000-06-22 | 2001-06-15 | 베타블록커 및 임의로 콜레스테롤 저하제를 포함하는신규한 제제 |
SK1807-2002A SK18072002A3 (sk) | 2000-06-22 | 2001-06-15 | Farmaceutické prípravky obsahujúce betablokátor a ich použitie |
PL36048401A PL360484A1 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
CA002411100A CA2411100A1 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
BR0111790-4A BR0111790A (pt) | 2000-06-22 | 2001-06-15 | Formulação farmacêutica, método para tratamento profilático ou terapêutico de um paciente sofrendo ou suscetìvel de sofrer de aterosclerose, uso de uma formulação farmacêutica, e, kit de partes |
PCT/SE2001/001380 WO2001097751A2 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
JP2002503228A JP2003535875A (ja) | 2000-06-22 | 2001-06-15 | 新規製剤 |
DE60124400T DE60124400T2 (de) | 2000-06-22 | 2001-06-15 | Verwendung eines betablockers zur behandlung von atherosklerose |
HU0302371A HUP0302371A3 (en) | 2000-06-22 | 2001-06-15 | New pharmaceutical composition comprising a betablocker and optionally a cholesterol-lowering agent |
CN01811540A CN1437484A (zh) | 2000-06-22 | 2001-06-15 | 含有β-受体阻滞剂和任选的降胆固醇剂的新型制剂 |
ZA200209908A ZA200209908B (en) | 2000-06-22 | 2002-12-05 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent. |
BG107373A BG107373A (bg) | 2000-06-22 | 2002-12-11 | Нов състав, съдържащ бета-блокер и евентуално средство, понижаващо холестерола |
IS6653A IS6653A (is) | 2000-06-22 | 2002-12-11 | Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni |
NO20026177A NO20026177D0 (no) | 2000-06-22 | 2002-12-20 | Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel |
HK03106811.1A HK1054508A1 (zh) | 2000-06-22 | 2003-09-22 | 新型製劑 |
US11/407,505 US20060252814A1 (en) | 2000-06-22 | 2006-04-19 | Formulation comprising a betablocker and optionally a cholestrol-lowering agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0002354D0 true SE0002354D0 (sv) | 2000-06-22 |
Family
ID=20280209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
Country Status (28)
Country | Link |
---|---|
US (2) | US20030191177A1 (bg) |
EP (1) | EP1296716B1 (bg) |
JP (1) | JP2003535875A (bg) |
KR (1) | KR20030010750A (bg) |
CN (1) | CN1437484A (bg) |
AR (1) | AR028699A1 (bg) |
AT (1) | ATE344675T1 (bg) |
AU (1) | AU2001274766A1 (bg) |
BG (1) | BG107373A (bg) |
BR (1) | BR0111790A (bg) |
CA (1) | CA2411100A1 (bg) |
CZ (1) | CZ20024181A3 (bg) |
DE (1) | DE60124400T2 (bg) |
EE (1) | EE200200703A (bg) |
ES (1) | ES2274892T3 (bg) |
HK (1) | HK1054508A1 (bg) |
HU (1) | HUP0302371A3 (bg) |
IL (1) | IL153245A0 (bg) |
IS (1) | IS6653A (bg) |
MX (1) | MXPA02012957A (bg) |
NO (1) | NO20026177D0 (bg) |
NZ (1) | NZ523188A (bg) |
PL (1) | PL360484A1 (bg) |
RU (1) | RU2271802C2 (bg) |
SE (1) | SE0002354D0 (bg) |
SK (1) | SK18072002A3 (bg) |
WO (1) | WO2001097751A2 (bg) |
ZA (1) | ZA200209908B (bg) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053683A1 (en) * | 2003-11-26 | 2005-06-16 | Duke University | A method of preventing or treating glaucoma |
KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
KR100836321B1 (ko) | 2006-10-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 모니터 장치 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
EP0677291A3 (en) * | 1991-03-18 | 1996-08-07 | Sepracor Inc | Composition and method containing optically pure S-metoprolol. |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
NO177455C (no) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Anordning ved apparat for fremstilling av brannslukkende skum |
CA2251972A1 (en) * | 1996-04-17 | 1997-10-23 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (sv) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
EA200100704A1 (ru) * | 1998-12-23 | 2002-02-28 | Джи.Ди.Сирл Ллс | Комбинация для применения по сердечно-сосудистым показаниям |
-
2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
-
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 EP EP01941409A patent/EP1296716B1/en not_active Expired - Lifetime
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Application Discontinuation
-
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-20 NO NO20026177A patent/NO20026177D0/no not_active Application Discontinuation
-
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
-
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030191177A1 (en) | 2003-10-09 |
DE60124400D1 (de) | 2006-12-21 |
EE200200703A (et) | 2004-08-16 |
KR20030010750A (ko) | 2003-02-05 |
NZ523188A (en) | 2006-06-30 |
DE60124400T2 (de) | 2007-10-31 |
ES2274892T3 (es) | 2007-06-01 |
BR0111790A (pt) | 2003-05-20 |
RU2271802C2 (ru) | 2006-03-20 |
HUP0302371A2 (hu) | 2003-11-28 |
NO20026177L (no) | 2002-12-20 |
SK18072002A3 (sk) | 2003-08-05 |
HK1054508A1 (zh) | 2003-12-05 |
ATE344675T1 (de) | 2006-11-15 |
WO2001097751A2 (en) | 2001-12-27 |
CN1437484A (zh) | 2003-08-20 |
CZ20024181A3 (cs) | 2003-04-16 |
PL360484A1 (en) | 2004-09-06 |
IS6653A (is) | 2002-12-11 |
CA2411100A1 (en) | 2001-12-27 |
IL153245A0 (en) | 2003-07-06 |
AU2001274766A1 (en) | 2002-01-02 |
AR028699A1 (es) | 2003-05-21 |
JP2003535875A (ja) | 2003-12-02 |
EP1296716B1 (en) | 2006-11-08 |
MXPA02012957A (es) | 2003-05-15 |
BG107373A (bg) | 2003-09-30 |
US20060252814A1 (en) | 2006-11-09 |
NO20026177D0 (no) | 2002-12-20 |
EP1296716A2 (en) | 2003-04-02 |
HUP0302371A3 (en) | 2007-03-28 |
ZA200209908B (en) | 2004-03-05 |
WO2001097751A3 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1412384E (pt) | Formulação estável de glp-1 modificado | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
PL309721A1 (en) | Pharmaceutical composition containing fluoxetin hydrochloride | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
ATE391708T1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
DE602004011966D1 (en) | Heterocyclylverbindungen | |
YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
SE0102440D0 (sv) | New compound | |
MXPA02009705A (es) | Nueva combinacion de un betabloqueador y un agente de disminucion de colesterol. | |
AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
SE0002354D0 (sv) | New formulation | |
SE9800905L (sv) | Ny terapi vid glomerulonefrit | |
YU24603A (sh) | Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin | |
MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. |